Business News/Market/Market Stats/   Sun Pharmaceutical Industries Q3 Results

Sun Pharmaceutical Industries Q3 Results

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs
1,191.40 -5.00 (-0.42%)Updated : 28 Nov 2023
Fiscal Period2023
Period End DateDec 22
Revenue 11240.97
Total Revenue 11240.97
Costof Revenue Total 2803.67
Gross Profit 8437.30
Selling/ General/ Admin Expenses Total 2037.07
Depreciation/ Amortization 659.95
Other Operating Expenses Total 3393.38
Total Operating Expense 8894.07
Operating Income 2346.90
Interest Inc( Exp) Net- Non- Op Total -493.10
Other Net 173.88
Net Income Before Taxes 2471.47
Provisionfor Income Taxes 283.43
Net Income After Taxes 2188.04
Minority Interest -14.74
Equity In Affiliates -72.90
Net Income Before Extra Items 2166.01
Net Income 2166.01
Income Availableto Com Excl Extra Ord 2166.01
Income Availableto Com Incl Extra Ord 2166.01
Diluted Net Income 2166.01
Diluted Weighted Average Shares 240.67
Diluted EPS Excluding Extra Ord Items 9.00
DPS- Common Stock Primary Issue 7.50
Diluted Normalized EPS 9.00
*All figures in crores except per share values
Recommended For You